About this trial
Low-residue diet (LRD) in patient improves the quality of the colon cleanliness and thus the adenoma detection rate (ADR). This is a key criterion in colonoscopy screening for colorectal cancer (CRC). The benefit of an LRD lasting more than 24 hours before colonoscopy has not been demonstrated compared to a 24-hour LRD.
Few studies have evaluated the benefit of a prepackaged 24-hour LRD compared to simply receiving oral and written LRD instructions during a consultation.
The aim of the study is to evaluate the usefulness of a prepackaged LRD (Colobox®) compared to simple LRD instructions on colon cleanliness (Boston score) in patients examined by endoscopy.
Eligibility criteria
Qualifiers
Patient of one of the investigators for total colonoscopy (no prior colonic surgery);
Patient aged 18 years or older;
Patient classified as ASA 1, ASA 2, or ASA 3;
Not participating in any other current clinical trial;
Disqualifiers
Patient taking major psychotropic medications;
Patient with uncontrolled diabetes;
Patient with coagulation abnormalities preventing polypectomy: PT <50%, Platelets <50,000/mm³, current effective anticoagulation therapy (clopidogrel, prasugrel, or ticagrelor);
Patient referred for removal of a known polyp;
Trial design
Treatments tested in this trial
- Colonoscopy
- Questionnaires
- Pre-colonoscopy diet according to the investigator's oral instructions
- Pre-colonoscopy diet by following a special preparation, Colobox.